Ranpak Q2 revenue beats analyst estimates on automation growth
Reuters2026/07/30 11:42
Overview
Packaging automation provider's Q2 revenue rose 14% yr/yr, beating analyst expectations
Adjusted EBITDA for Q2 increased 15.8% yr/yr to $19.1 mln
Company saw strong automation revenue growth, but net loss widened to $7.9 mln
Outlook
Ranpak expects 2026 Automation revenue to reach nearly $60 mln
Company continues to expect to achieve its full-year 2026 guidance
Ranpak says global conflicts are creating near-term volatility and uncertainty
Result Drivers
AUTOMATION GROWTH - Automation product line revenue rose 133.8% yr/yr, driven by increased adoption of box customization and automated dunnage insertion solutions
CONSUMABLE VOLUME - Paper consumable product volumes increased 2.4% yr/yr, led by growth in EMEA region
CUSHIONING DECLINE - Cushioning revenue fell 4.6% yr/yr, partially offsetting growth in other segments
Company press release: ID:nBw3lZZhra
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 Revenue |
Beat |
$105.20 mln |
$100.94 mln (3 Analysts) |
Q2 Net Loss |
|
$7.90 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the paper packaging peer group is "buy"
Wall Street's median 12-month price target for Ranpak Holdings Corp is $7.25, about 24.1% above its July 29 closing price of $5.84
Reuters Recommended Reads
July 29 - Industrial products maker Fortive lifts profit view on strong automation business
July 30 - Mondi shares surge as price hikes, cost cuts to drive second-half profits
July 29 - Smurfit Westrock downgrades full-year profit guidance on freight costs
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cutting Canada tariffs alone won’t flatten US aluminum premium, Alcoa says
Clover Health Investments Shares Rise After Deutsche Bank Initiates Coverage With a Buy Rating
Alzinova issues new warrants alongside SEK 51 million rights offering
Orchestra BioMed Shares Rise After BTIG Upgrade